Larin Fe 1/20 Kit
Product Images NDC 16714-406

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Larin Fe 1/20 (NDC 16714-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Norethindrone Acetate Ethinyl Estradiol is a combination medication that contains two hormones, norethindrone acetate and ethinyl estradiol. It is commonly used as an oral contraceptive, but may also be used to treat other conditions such as irregular periods, endometriosis, or menopausal symptoms.*

FDA Label Image

2 (Image 02)

This text provides a table with the lowest expected and typical (typical couples being those who initiate use of a method) failure rates during the first year of continuous use of various contraceptives. The percentage of women experiencing an unintended pregnancy is given for each method, including oral contraceptives, diaphragms, spermicides, condoms, and sterilization. Some methods have an N/A due to data not being available.*

FDA Label Image

3 (Image 03)

Cigarette smoking and oral contraceptives are not recommended together as smoking increases the risk of severe cardiovascular side effects. The risk is greater with age and heavy smoking, particularly in women over 33 years old. It is advised that women who use oral contraceptives should not smoke.*

FDA Label Image

4 (Image 04)

FDA Label Image

5 (Image 05)

This is a table that shows the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method according to age. The methods of control mentioned are oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence. The age groups considered are 15-19, 20-24, 25-29, and 40-44. The deaths mentioned are either birth-related or method-related. The data is adapted from reference 41 by H.W. Ory.*

FDA Label Image

6 (Image 06)

Cigarette smoking and the use of oral contraceptives can lead to serious cardiovascular side effects, especially in women over 35 years of age. Heavy smoking (15 or more cigarettes per day) increases this risk even more. Women who use oral contraceptives should avoid smoking to minimize their risk of these side effects.*

FDA Label Image

7 (Image 07)

This is a set of instructions for women taking pills as a form of birth control. The text provides guidance for both Sunday starters and Day-1 starters, which are women whose menstrual cycle begins on a day other than Sunday. The instructions include placing a day label strip, taking pills from left to right each week, and an example is also provided.*

FDA Label Image

8 (Image 08)

Cigarette smoking and oral contraceptive use increase the risk of serious cardiovascular complications. This risk is particularly high in women over 35 years of age who smoke heavily (15 or more cigarettes per day). It is strongly advised that women using oral contraceptives do not smoke.*

FDA Label Image

9 (Image 09)

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives are strongly advised not to smoke.*

FDA Label Image

10 (Image 10)

This is a statistics report indicating the annual number of birth-related or method-related deaths associated with fertility control methods for nonsterile women according to age. The report includes data for different age groups and different methods of fertility control, such as no method, oral contraceptives, TUD, condoms, diaphragm/spermicide, and periodic abstinence. The number of deaths is specified as birth-related or method-related. This report can be used to evaluate the safety and effectiveness of different options for fertility control.*

FDA Label Image

11 (Image 11)

This text appears to be a set of instructions for starting a birth control pill pack. The pack can be started either on a Sunday or on the first day of a menstrual cycle that starts on a day other than Sunday. The instructions include placing a labeled strip starting with the first day of the menstrual cycle on the appropriate day of the pill pack. The pills should be taken in a specific direction, from left to right each week.*

FDA Label Image

12 (Image 12)

FDA Label Image

13 (Image 13)

LARIN' Fe 28, DorehindoseAette g, EhinyEstadoTalets USP, and Fercus Fumaale i'} are names of medications, however due to the fragmented and unclear nature of the text, it is difficult to provide a more specific description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.